All companies
Visit website
HERBAL BOTANICAL PRODUCTS, LLC
OperatingHerbal Botanical Products, LLC
Healthcare · Fitness · Founded 2020
Topical pain management products, infused with CBD isolate, Nano CBD and CBG
Post-money valuation ⓘ
$12.6M
As of Sep 2023 · from HERBAL BOTANICAL PRODUCTS, LLC Preferred Units 1 · pre-money + amount raised, not a traded price
Total raised
$52,500
Across 1 round since 2023
Latest share price
$100.00
HERBAL BOTANICAL PRODUCTS, LLC Preferred Units 1 offering price
Financials
FY2021–FY2022 · from SEC filings · hover any figure for its source$20K
−$189K
2021
$16K
−$240K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
Income statement
Revenue
$20,196
$16,000
Cost of goods sold
$5,426
$5,758
Gross margin
73%
64%
Net income
-$188,904
-$239,509
Taxes paid
$0
$0
Balance sheet
Cash
$67,003
$34,264
Accounts receivable
$0
$0
Total assets
$283,611
$316,301
Short-term debt
$68,183
$74,265
Long-term debt
$0
$0
Total liabilities
$68,183
$74,265
Other
Headcount
—
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$12.6M
post-money
HERBAL BOTANICAL PRODUCTS, LLC Preferred Units 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $52.5K / $124KInvestors 15Post-money $12.6M
Reg CF annual-report compliance
Delinquent
Filed 0 of 3 annual reports (FY2023–FY2025)
Missing: 2023, 2024, 2025
15 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
- Form CMay 12, 20230001670254-23-000544EDGAR
Source: ManualCIK 0001975317Share price $100.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.